Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 18883 participants.
Also called NCT02810704
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose supportive care
- Phase
- Phase 4
- Enrolled
- 18,883 participants
- Sponsor
- Registry
-
NCT02810704
-
- Other papers using this trial's data
- Prevention of Venous Thromboembolism after Total Hip or Knee Replacement
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States, Canada
- Registry status
- Completed
Technical summary
Registry record NCT02810704. Randomized; no masking; primary purpose supportive care. Start 2016-12 (actual); primary completion 2025-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement
- Acronym
- PEPPER
- Condition
- Pulmonary Embolism
- Condition
- Venous Thrombosis
- Intervention (Drug)
- Enteric Coated Aspirin
- Intervention (Drug)
- Warfarin
- Intervention (Drug)
- Rivaroxaban
- Lead sponsor
- Dartmouth-Hitchcock Medical Center
- Collaborator
- Patient-Centered Outcomes Research Institute
- Collaborator
- University of Maryland, Baltimore
- Collaborator
- Brigham and Women's Hospital
- Collaborator
- Northwestern University
- Collaborator
- Medical University of South Carolina
Record details
- Record id
cardio:ct-nct02810704- Content hash
139bbb89ee5dc5b844d6f1b3ed46fa9a4291e9fc79b4a1b1293bbdb2de8a4b47